Related Experiment Video

Updated: Aug 20, 2026

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
09:58

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Published on: January 7, 2019

Analysis of Bcl-2 and p53 protein expression in non-Hodgkin's lymphoma

M R Hussein, T M Al-Sabae, M N Georgis

    Annals of Oncology : Official Journal of the European Society for Medical Oncology
    |November 20, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
    07:52

    Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

    Published on: January 9, 2019

    Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
    09:32

    Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

    Published on: September 10, 2017

    Related Experiment Videos

    Last Updated: Aug 20, 2026

    Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
    09:58

    Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

    Published on: January 7, 2019

    Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
    07:52

    Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

    Published on: January 9, 2019

    Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
    09:32

    Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

    Published on: September 10, 2017

    Related Concept Videos

    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

    Articles linked to this work by shared authors, journal, and citation graph.

    Electrochemical evaluation of EVA/ZnO nanocomposite coatings: achieving superior electrochemical corrosion protection in harsh environments.

    RSC advances·2025

    Telocytes in Cutaneous Biology: A Reappraisal.

    Actas dermo-sifiliograficas·2023

    Expression Profile of CD10, BCL-2, p63, and EMA in the Normal Skin and Basal Cell Carcinomas: An Immunohistochemical Reappraisal.

    Actas dermo-sifiliograficas·2022

    Hurthle cell neoplasms of thyroid in south-western region of Saudi Arabia.

    West African journal of medicine·2011

    Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings.

    Clinical and experimental immunology·2006

    Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations.

    Journal of clinical pathology·2006

    Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us